NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Tappenden P, Carroll C, Hamilton J, et al. Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model. Southampton (UK): NIHR Journals Library; 2019 Feb. (Health Technology Assessment, No. 23.8.)
Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model.
Show details- Additional tables and figures relating to the Sanofi model - Cabozantinib and va...Additional tables and figures relating to the Sanofi model - Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model
Your browsing activity is empty.
Activity recording is turned off.
See more...